In this study, we sought to devise a photoimmunoconjugate formulation that combines hydrophobic BPD photosensitizers and a conformation-sensitive UIC2 monoclonal antibody to identify ABCB1 expression on triple negative breast cancer (TNBC) cells. Here, ABCB1 is linked to triple-negative breast carcinoma.